These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23710436)

  • 1. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis.
    Luo J; Wen H; Guo H; Cai Q; Li S; Li X
    Biomed Res Int; 2013; 2013():101805. PubMed ID: 23710436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
    Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
    BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A.
    Feng X; Lv C; Wang F; Gan K; Zhang M; Tan W
    Clin Dev Immunol; 2013; 2013():160123. PubMed ID: 24348674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F
    Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.
    Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G
    Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway.
    Liu XY; Xu L; Wang Y; Li JX; Zhang Y; Zhang C; Wang SS; Zhang XM
    Int Immunopharmacol; 2017 Mar; 44():105-114. PubMed ID: 28092862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures.
    Giganti MG; Liuni F; Celi M; Gasbarra E; Zenobi R; Tresoldi I; Modesti A; Bei R; Tarantino U
    J Biol Regul Homeost Agents; 2012; 26(4):671-80. PubMed ID: 23241117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S; Wang Y; Lu J; Xu J
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.
    Remuzgo-Martínez S; Genre F; López-Mejías R; Ubilla B; Mijares V; Pina T; Corrales A; Blanco R; Martín J; Llorca J; González-Gay MA
    Sci Rep; 2016 Jul; 6():29713. PubMed ID: 27403809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
    Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
    Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.
    Lange U; Dischereit G; Tarner I; Frommer K; Neumann E; Müller-Ladner U; Kürten B
    Clin Rheumatol; 2016 Nov; 35(11):2783-2788. PubMed ID: 27053095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1,25(OH)2-Vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis].
    Wen H; Luo J; Zhang X; Zhang C; Zhao X; Wang X; Li X
    Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):317-21. PubMed ID: 26268060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D
    Wen HY; Luo J; Li XF; Wei DD; Liu Y
    Immunol Res; 2019 Feb; 67(1):48-57. PubMed ID: 30357602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.